Skip to content

Efficacy of Triphaladi Ghana Vati, Arjunadi Lepa and Medhya Rasayan Ghana Vati in patients of pimples(acne)

Efficacy of Triphaladi Ghana Vati and Arjunadi Lepa with or without Medhya Rasayan Ghana Vati in the management of Yauvanpidika (Acne Vulgaris): An Open Labelled Randomized Comparative Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051783
Enrollment
30
Registered
2023-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients suffering from classical sign and symptoms along with stress induced Yauvanpidika. 2)Age group - 18-30 years. 3)Patients willing to accept the participation in the clinical trial.

Exclusion criteria

Exclusion criteria: 1)Age below 18 years and above 30 years. 2)Having history of any systemic disease like D.M., cardiac disease, renal disorder, Prameha Pidika, Masurika etc. or any viral infection will be excluded from the present study. 3)Patients not willing to participate in the trial as per protocol.

Design outcomes

Primary

MeasureTime frame
To improve the signs and symptoms of Yauvanpidika (like having shape of shalmali kantak, saruja, ghana,medo garbhaj pidika) & the psychological imbalance i.e.stress etc. Timepoint: On 0 day and after 8 weeks

Secondary

MeasureTime frame
To improve the lustre and complexion of the skin. To improve the quality of life in patient of Yauvanpidika (Acne vulgaris). Timepoint: On 0 day and after 8 weeks

Countries

India

Contacts

Public ContactDr Hetal Vyas

Institute of teaching and research in Ayurveda Jamnagar

vyashetal1979@gmail.com9427941558

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026